SuperworthLakewood-Amedex Biotherapeutics LABT
Drug Manufacturers - General, Healthcare
$0.31
−36.67%
- Market cap
- $734.6K
- PE
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- n/m
- not a meaningful number
- EV/EBIT
- n/m
- not a meaningful number
- Revenue, 12 months
- n/m
- not a meaningful number
- Net margin
- n/m
- not a meaningful number
- Free cash flow yield
- n/m
- not a meaningful number
Charts
Financials
| Income statement | Q1 FY25 | Q2 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|
| R&D | $169.7K | $146.9K | $182.1K | $503K |
| SG&A | $371.7K | $489.3K | $703.4K | $3.3M |
| −$542.6K | −$637.4K | −$886.8K | −$3.8M | |
| Interest expense | $1.3K | $23.9K | $38.2K | $10.6K |
| Net income | −$539.6K | −$655.9K | −$923.3K | −$3.8M |
| −$1.50 | −$1.66 | −$2.00 | −$2.75 | |
| 694.3K | 694.5K | 699.5K | 1.4M |
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Drug Manufacturers - General nearest Lakewood-Amedex Biotherapeutics' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| LABTLakewood-Amedex Biotherapeutics | $734.6K | n/m | n/a | n/m | n/m | n/m | |
| NXTSNexentis Technologies | $761.8K | n/m | n/a | n/m | n/m | n/m | |
| JAGXJaguar Health | $702.9K | n/m | n/a | 0.0× | +136% | n/m | |
| VBIOValion Bio | $834.3K | n/m | n/a | n/m | n/m | n/m | |
| DCOYDecoy Therapeutics | $635.5K | n/m | n/a | n/m | n/m | n/m | |
| SBFMSunshine Biopharma | $581.6K | n/m | n/a | 0.0× | −3% | −16.5% | |
| ARTLArtelo Biosciences | $1.3M | n/m | n/a | n/m | n/m | n/m | |
| LNAILunai Bioworks | $1.5M | n/m | n/a | n/m | n/m | n/m | |
| GNPXGenprex | $1.5M | n/m | n/a | n/m | n/m | n/m | |
| GOVXGeoVax Labs | $1.5M | n/m | n/a | n/a | −100% | n/a | |
| ONCOOnconetix | $1.7M | n/m | n/a | n/m | n/m | n/m | |
| Peer median | $1.1M | n/a | n/a | 0.0× | −3% | −16.5% |
More on Lakewood-Amedex Biotherapeutics
Each number over time
Its groups
About
- Industry
- Drug Manufacturers - General
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .